Atlas Trials

Clinical Trial of COVID-19 Vaccine(SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine) in Participants Aged 18 Years and Over

Clinical trial NCT05745545 · UNKNOWN

Trial details

NCT number
NCT05745545
Sponsor
AIM Vaccine Co., Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
SARS-CoV-2
Start date
2023-01-04
Primary completion
2023-09-01
Enrollment
3200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.